Advances in understanding and exploiting Siglec-glycan interactions
- PMID: 38631213
- DOI: 10.1016/j.cbpa.2024.102454
Advances in understanding and exploiting Siglec-glycan interactions
Abstract
Sialic-acid-binding immunoglobulin-type lectins (Siglecs) are a family of cell-surface immunomodulatory receptors that recognize sialic-acid-containing glycans. The majority of Siglecs have an inhibitory motif in their intercellular domain and can regulate the cellular activation of immune cells. Importantly, the immunomodulatory role of Siglecs is regulated by engagement with distinct sialoglycan ligands. However, there are still many unanswered questions about the precise ligand(s) recognized by individual Siglec family members. New tools and approaches to study Siglec-ligand interactions are rapidly filling this knowledge gap. This review provides an overview of recent advances in discovering Siglec ligands as well as the development of approaches to modulate the function of Siglecs. In both aspects, chemical biology approaches are emphasized with a discussion on how these are complementing biochemical and genetic strategies.
Keywords: Carbohydrate; Glycans; Immunomodulation; Sialic acid; Siglecs.
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Matthew S Macauley reports financial support was provided by Canada Research Chairs. Taylor E Gray reports financial support was provided by Natural Sciences and Engineering Research Council of Canada. Matthew S. Macauley has patent #Targeting Siglec-6 with glycan ligands pending to University of Alberta. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Carbohydrate sulfation as a critical modulator of siglec-sialoglycan interactions.Carbohydr Res. 2025 Jul;553:109502. doi: 10.1016/j.carres.2025.109502. Epub 2025 Apr 25. Carbohydr Res. 2025. PMID: 40328158 Review.
-
Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation.Org Biomol Chem. 2020 Aug 5;18(30):5784-5797. doi: 10.1039/d0ob01116a. Org Biomol Chem. 2020. PMID: 32756649 Review.
-
Roles for Siglec-glycan interactions in regulating immune cells.Semin Immunol. 2025 Mar;77:101925. doi: 10.1016/j.smim.2024.101925. Epub 2024 Dec 19. Semin Immunol. 2025. PMID: 39706106 Review.
-
Flow Cytometry-Based Detection of Siglec Ligands.Methods Mol Biol. 2023;2657:181-193. doi: 10.1007/978-1-0716-3151-5_13. Methods Mol Biol. 2023. PMID: 37149531
-
Current Status on Therapeutic Molecules Targeting Siglec Receptors.Cells. 2020 Dec 15;9(12):2691. doi: 10.3390/cells9122691. Cells. 2020. PMID: 33333862 Free PMC article. Review.
Cited by
-
Engineered Proteins and Chemical Tools to Probe the Cell Surface Proteome.Chem Rev. 2025 Apr 23;125(8):4069-4110. doi: 10.1021/acs.chemrev.4c00554. Epub 2025 Apr 3. Chem Rev. 2025. PMID: 40178992 Free PMC article. Review.
-
Exploring Glycan-Lectin Interactions in Natural-Like Environments: A View Using NMR Experiments Inside Cell and on Cell Surface.Chemistry. 2025 Feb 17;31(10):e202403102. doi: 10.1002/chem.202403102. Epub 2024 Dec 11. Chemistry. 2025. PMID: 39588609 Free PMC article.
-
An ultrasensitive and modular platform to detect Siglec ligands and control immune cell function.bioRxiv [Preprint]. 2025 Jun 12:2025.06.10.658684. doi: 10.1101/2025.06.10.658684. bioRxiv. 2025. PMID: 40661511 Free PMC article. Preprint.
-
Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases.Int J Mol Sci. 2024 Nov 7;25(22):11962. doi: 10.3390/ijms252211962. Int J Mol Sci. 2024. PMID: 39596031 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous